<DOC>
	<DOCNO>NCT02107326</DOCNO>
	<brief_summary>The purpose study evaluate impact software smartphones tablet type 1 diabetes control quality life</brief_summary>
	<brief_title>Randomized Crossover Study Test Impact Using Software Smartphones Tablets Treating Type 1 Diabetes</brief_title>
	<detailed_description>The hypothesis underlie project , calculation necessary flexible intensive insulin therapy type 1 diabetes child perform use software instal smartphone tablet nowadays carry parent child . Smartphones tablet easily communicate desktop computer via Internet , thereby permit exchange information blood glucose value type meal among family member physician . Finally , software collect blood glucose value merge value obtain different device easily permit review value patient send physician 's office , thereby avoid consultation blood glucose value bring patient . We hypothesize Webdia software , test randomize crossover study , increase treatment compliance therefore improve diabetes self-management . We believe , software facilitate adaptation insulin scheme physician therefore lead improved HbA1C value . We also think software improve patient 's quality life .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>Age 10 18 year Type 1 diabetes mellitus positive autoantibody Islet Antigen ( IA ) 2 , insulin , islet , Glutamic Acid Decarboxylase ( GAD ) 65 Zink Disease duration equal 6 month Treatment subcutaneous insulin : multiple daily injection pump therapy Previous use Webdia Software Absence hardware necessary install Webdia Software</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>HbA1C</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Hypoglycaemia</keyword>
	<keyword>Self-management</keyword>
	<keyword>Telemedicine</keyword>
</DOC>